Skip to main content

Table 2 Association between CIP2A expression in patients with acute myeloid leukemia and demographic characteristics, clinical and laboratory data, and risk stratification

From: Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients

ParameterCIP2A expressionP value
 High (n = 21)Low (n = 39) 
 Value (mean ± SD) or distribution
(n (%))
Value (mean ± SD) or distribution
(n (%))
 
Age (years)33.8 ± 2.738.5 ± 2.00.17
Gender0.83
 Male9 (33.3)18 (66.7) 
 Female12 (36.3)21 (63.7) 
Hepatomegaly7 (28.0)18 (72.0)0.28
Splenomegaly5 (21.7)18 (78.2)0.11
Lymphadenopathy1 (8.3)11 (91.6)0.04
Total leukocyte count (× 109/L)41.6 ± 10.654.3 ± 10.20.43
Hemoglobin (g/dL)8.2 ± 0.48.0 ± 0.30.81
Platelets (× 109/L)45.5 ± 9.662.8 ± 14.30.41
Peripheral-blood blasts45.8 ± 5.647.9 ± 4.50.78
Bone-marrow blasts58.7 ± 4.361.7 ± 3.60.61
FLT30.38
 Wild type19 (90.5)32 (82.1) 
 Mutant2 (9.5)7 (17.9) 
Risk stratification0.94
 Favorable5 (23.8)9 (23.1) 
 Intermediate3 (14.3)8 (20.5) 
 Poor5 (23.8)9 (23.1) 
 Not performed8 (38.1)13 (33.3)